Insider · CIK 0001186877
Michael J Berendt
Files at RTSN (Retension Pharmaceuticals, Inc.). First filing -, latest -.
Michael J Berendt files SEC Form 4 as director at RTSN (Retension Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael J Berendt has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | RTSN Retension Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +5,636 | $0.00 | $0 | 5,636 | 5 d ago |
Questions about Michael J Berendt
Answered from the filings on this page, as of the latest one.
Is Michael J Berendt buying or selling?
Michael J Berendt has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael J Berendt's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael J Berendt has 0.
Where does Michael J Berendt file Form 4?
Michael J Berendt has filed Form 4 at RTSN (Retension Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.